Stock Market Impact: Shares of Sunshine Biopharma Inc. (NASDAQ:SBFM) dropped 21% on Thursday after the company announced a one‑for‑ten reverse stock split, indicating a strong negative market reaction to the corporate action.
Listed Companies and Sectors: The announcement pertains to Sunshine Biopharma Inc., a pharmaceutical firm focused on generic and specialty prescription medications, and may affect the broader Pharmaceuticals sector due to heightened attention on Nasdaq compliance issues.
Investment Flows: No specific measures affecting foreign direct investment (FDI) or foreign portfolio investment (FPI) were mentioned; the event is confined to the company’s capital structure.
Interest Rates, Inflation, and Liquidity: The article does not reference any changes to interest rates, inflation, or liquidity conditions.
Fiscal or Monetary Policy: No fiscal or monetary policy actions are discussed in relation to the reverse split.
